Administration of Raloxifene (an estrogen receptor modulator) was found to significantly decrease Gas6 levels in aortic valves of rats, with down-regulation of Gas6/Axl pathway and decreased aortic valve calcification [79]. This evidence concerns the gene GAS6 and aortic valve calcification.